Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_assertion type Assertion NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_head.
- NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_provenance.
- NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_assertion evidence source_evidence_curated NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_provenance.
- NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_assertion SIO_000772 17295095 NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_provenance.
- NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_assertion wasDerivedFrom ctd_human-20150221 NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_provenance.
- NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_assertion wasGeneratedBy ECO_0000218 NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_provenance.